CTNM
Financials
- Market Capitalization 337.94 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3212 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.99 USD | 0.00% | -0.33% | +58.20% | +164.60% | 348.51 M USD | ||
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.78 USD | +0.21% | -1.24% | +35.41% | +243.88% | 340.27 M USD | ||
| 3236 |  HELP Cybin Inc. - Common Stock | 6.51 USD | -2.54% | +5.68% | +51.04% | -27.42% | 336.12 M USD | ||
| 3239 |  IMRX Immuneering Corporation - Class A Common Stock | 5.16 USD | -0.96% | -5.15% | +24.04% | +28.68% | 333.84 M USD |
Frequently asked questions about Contineum Therapeutics, Inc. - Common stock
What is the Contineum Therapeutics, Inc. - Common stock stock price today?
The current price of Contineum Therapeutics, Inc. - Common stock (CTNM) is 14.63. Over the past 24 hours, the stock has changed by +0.41%. Follow the CTNM chart for real-time price dynamics.
What is the stock ticker of Contineum Therapeutics, Inc. - Common stock?
Contineum Therapeutics, Inc. - Common stock trades under the ticker CTNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Contineum Therapeutics, Inc. - Common stock stock going up?
CTNM has changed by -6.76% over the last week, +18.94% over the last month, and -4.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Contineum Therapeutics, Inc. - Common stock net income for the last quarter?
Contineum Therapeutics, Inc. - Common stock reported net income of -14.46 M for the last quarter. The previous quarter showed -15.16 M, which means net income changed by +4.62%.
How many employees does Contineum Therapeutics, Inc. - Common stock have?
As of the latest available data, Contineum Therapeutics, Inc. - Common stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Contineum Therapeutics, Inc. - Common stock stock?
You can buy Contineum Therapeutics, Inc. - Common stock (CTNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Contineum Therapeutics, Inc. - Common stock stock?
Investing in Contineum Therapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTNM chart and related analysis on metatrader.com as part of your research.